Florida’s surgeon general said Sunday that he had not weighed the cost – in terms of infections, hospitalizations or deaths – ...

The outlook for the PDE4B inhibitors market is changing as this drug class demonstrates significant therapeutic promise in respiratory, dermatologic, and inflammatory diseases. Existing approvals such ...